Valeant planning hostile takeover bid as Botox maker Allergan rejects acquisition proposals
NEW YORK, N.Y. - Valeant plans to take a buyout offer for Allergan directly to its shareholders this week, as the Botox maker continues to rebuff its proposals.
Valeant Pharmaceuticals International Inc. Chairman and CEO J. Michael Pearson said in a conference call Tuesday that proxies seeking support for its bid may be mailed in "the near-term."
He said that "It is clear Allergan's management and their board will never sit down and act in the interest of their shareholders." Pearson says the Canadian company believes an Allergan shareholder vote would "be overwhelmingly in support of the deal."
The latest bid from Valeant and Bill Ackman's Pershing Square Capital Management is worth $53 billion.
California-based Allergan Inc. has repeatedly rejected offers as underpriced and risky.
Read more Business News
- Dog killed in coyote attackPenticton / S. Okanagan - 5:00 am
- Builder sought for new hospitalPenticton / S. Okanagan - 6:00 am
- ATV crash kills driverKelowna
- Big group hug effortPenticton / S. Okanagan - 5:00 am
|QHR Technologies Inc||1.25||-0.05|
|Anavex Life Sciences||0.2361||-0.0139|
|Copper Mountain Mining||2.73||+0.04|
|Sunrise Resources Ltd||0.02||-0.005|
|Mission Ready Services||0.29||-0.01|
There will be a time when you will need to decide who you should appoint as executor of your Will. As well, there may be a time when you will be asked by someone to act as the executor of his or her W...
Part 1 of 2 Photo: Thinkstock.com1. Move in with your parents or in-laws Explain that you're thinking strategically in moving back home. The quickest way to get into the housing market is to ma...
Article written by Linda Bustos Though I’d never recommend “lowest prices” as a unique selling proposition, I notice many retailers use a Price Match Guarantee or even a 110% Guara...